Avation

Columbus, United States Founded: 1999 • Age: 27 yrs
Wearable tibial nerve stimulation device treats overactive bladder symptoms.
Request Access

About Avation

Avation is a company based in Columbus (United States) founded in 1999 by Manish Vaishya. It operates as a Direct-to-Consumer (D2C), and HealthTech. Avation has raised $34.92 million across 2 funding rounds from investors including Medtronic, Asahi Kasei and ShangBay Capital. Avation offers products and services including Vivally® System. Avation operates in a competitive market with competitors including Tulavi Nerve Therapeutics, BioCircuit, RxFunction, Epineuron and Monarch Bioimplants, among others.

  • Headquarter Columbus, United States
  • Founders Manish Vaishya
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Avation Medical
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $34.92 M (USD)

    in 2 rounds

  • Latest Funding Round
    $22 M (USD), Series C

    Feb 01, 2024

  • Investors
    Medtronic

    & 6 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Avation

Avation offers a comprehensive portfolio of products and services, including Vivally® System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Wearable treatment for overactive bladder is provided.

People of Avation
Headcount 10-50
Employee Profiles 10
Board Members and Advisors 7
Employee Profiles
People
Jill Schiaparelli
CEO & Director
People
Darren Wennen
CMO
People
Tracy Cameron
Clinical Consultant
People
Manish Vaishya
CTO

Unlock access to complete

Board Members and Advisors
people
Tom Shehab
Chairperson
people
Ali Rezai
Board Observer
people
Raymond Huggenberger
Director
people
Renee Selman
Director

Unlock access to complete

Funding Insights of Avation

Avation has successfully raised a total of $34.92M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $22 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series C — $22.0M
  • First Round

    (03 Feb 2021)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2024 Amount Series C - Avation Valuation ShangBay Capital , Asahi Kasei
Feb, 2021 Amount Series B - Avation Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Avation

Avation has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Asahi Kasei and ShangBay Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Angelini Ventures is focused on investing in BioTech and Digital Health.
Founded Year Domain Location
Healthcare venture capital investments are made by Arboretum Ventures.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Avation

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Avation

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Avation Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Avation

Avation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tulavi Nerve Therapeutics, BioCircuit, RxFunction, Epineuron and Monarch Bioimplants, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutic devices for neurally mediated diseases are developed.
domain founded_year HQ Location
Non-invasive electrophysiology devices are developed to monitor peripheral nerves.
domain founded_year HQ Location
Wearable prostheses for sensory peripheral neuropathy patients are developed.
domain founded_year HQ Location
Medical devices for peripheral nerve injury treatment are provided.
domain founded_year HQ Location
Developer of bioimplant for peripheral nerve repair
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Avation

Frequently Asked Questions about Avation

When was Avation founded?

Avation was founded in 1999 and raised its 1st funding round 22 years after it was founded.

Where is Avation located?

Avation is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.

Is Avation a funded company?

Avation is a funded company, having raised a total of $34.92M across 2 funding rounds to date. The company's 1st funding round was a Series B of $12.92M, raised on Feb 03, 2021.

What does Avation do?

Avation is focused on providing innovative solutions for overactive bladder (OAB) through the Vivally System, a wearable at-home treatment. The system is FDA-cleared and targets symptoms like incontinence and urgency with physiologic closed-loop controlled transcutaneous tibial nerve stimulation. It is supported by a mobile app for tracking progress and customer care for patient assistance. The healthcare sector is primarily served, with solutions designed for both patients and providers to improve quality of life.

Who are the top competitors of Avation?

Avation's top competitors include Tulavi Nerve Therapeutics, Epineuron and RxFunction.

What products or services does Avation offer?

Avation offers Vivally® System.

Who are Avation's investors?

Avation has 7 investors. Key investors include Medtronic, Asahi Kasei, ShangBay Capital, Angelini Ventures, and JobsOhio.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available